いびき防止デバイス：市場洞察・競合環境・市場予測 (～2030年)

いびき防止デバイスの市場規模は、2023年の16億1,000万米ドルから、2024年から2030年までの予測期間中はCAGR 7.02％で推移し、2030年には25億8,000万米ドルの規模に成長すると予測されています。

いびき防止デバイス市場は、睡眠障害やうつ病、COPD、肥満などの危険因子の有病率の増加、睡眠の重要性を強調する睡眠啓発キャンペーンやプログラムの急増、2024年から2030年までの予測期間中に技術的に高度な睡眠デバイスの発売が増加する見通しであることなどから、大幅な成長が見込まれています。

DelveInsightの分析によると、2021年に主要7カ国で診断された閉塞性睡眠時無呼吸症候群 (OSA) の推定総症例数は2,416万5,544例でした。2021年の世界保健機関 (WHO) の報告によると、2019年には世界で約2億8,000万人がうつ病に苦しんでいます。いくつかの研究によると、うつ病患者は、夜間に入眠・睡眠を維持することが困難であったり、日中に過度の眠気に襲われたりすることがあると報告されています。

また、Global Burden of Disease Studyのデータによると、2019年に世界で報告されたCOPDの有病者数は2億1,230万人でした。COPDは、呼吸困難、咳、痰の発生などの呼吸器症状を持続的かつ進行的に引き起こします。そのため、COPDの患者は睡眠時無呼吸症候群も併発し、その組み合わせで「オーバーラップ症候群」と呼ばれる状態になります。

肥満などの重篤な状態もまた、さまざまな睡眠障害の症状を悪化させ、個人の睡眠の質を乱す可能性があります。肥満の場合、上気道に脂肪がたまり気道が狭くなり、この部位の筋活動が低下して低酸素症や無呼吸のエピソードが生じ、睡眠時無呼吸症候群などの睡眠障害を引き起こします。これらの要因の相互作用が予測期間中の市場を後押しすると予想されます。

当レポートでは、世界のいびき防止デバイスの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域/主要国別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 いびき防止デバイス市場：イントロダクション

第2章 いびき防止デバイス市場：エグゼクティブサマリー

第3章 競合情勢

第4章 規制分析

• 米国
• 欧州
• 日本
• 中国

第5章 いびき防止デバイス市場：主要要因分析

• 市場促進要因
  • 睡眠障害の有病率と、うつ病、COPD、肥満などのリスク要因の増加
  • 睡眠の重要性を強調する睡眠啓発キャンペーンやプログラムの急増
  • 技術的に高度な睡眠デバイスの発売増加
• 市場抑制要因と課題
  • デバイスに関連する合併症
  • デバイス使用の有効性に対する信頼性の低さと実証された研究の欠如
• 市場機会
  • 睡眠デバイスのR&D活動の増加
  • 睡眠の追跡と支援におけるAI技術の採用増加

第6章 いびき防止デバイス市場：ポーターのファイブフォース分析

第7章 いびき防止デバイス市場：市場評価

• デバイスタイプ別
  • 下顎前方移動デバイス
  • 舌固定デバイス
  • 持続陽圧呼吸療法 (CPAP) デバイス
  • その他
• 流通チャネル別
  • 病院および薬局
  • オンライン薬局
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • その他の地域

第8章 いびき防止デバイス市場：企業および製品プロファイル

• Koninklijke Philips NV
• Apnea Sciences
• ResMed
• SomnoMed
• GSK plc.
• Meditas
• Evantis Inc.
• Rotech Healthcare
• The Pure Sleep Company
• Innovative Health Technologies
• Tomed GmbH
• Fisher and Paykel Healthcare Limited
• Whole You Inc.
• AccuMED Corporation
• Vyaire Medical

第9章 KOLの見解

第10章 プロジェクトアプローチ

第11章 DelveInsightについて

第12章 免責事項・お問い合わせ

List of Tables

• Table 1: Competitive Analysis
• Table 2: Anti Snoring Devices Market in Global (2021-2030)
• Table 3: Anti Snoring Devices Market in Global by Device Type (2021-2030)
• Table 4: Anti Snoring Devices Market in Distribution Channel (2021-2030)
• Table 5: Anti Snoring Devices Market in Global by Geography (2021-2030)
• Table 6: Anti Snoring Devices Market in North America (2021-2030)
• Table 7: Anti Snoring Devices Market in the United States (2021-2030)
• Table 8: Anti Snoring Devices Market in Canada (2021-2030)
• Table 9: Anti Snoring Devices Market in Mexico (2021-2030)
• Table 10: Anti Snoring Devices Market in Europe (2021-2030)
• Table 11: Anti Snoring Devices Market in France (2021-2030)
• Table 12: Anti Snoring Devices Market in Germany (2021-2030)
• Table 13: Anti Snoring Devices Market in United Kingdom (2021-2030)
• Table 14: Anti Snoring Devices Market in Italy (2021-2030)
• Table 15: Anti Snoring Devices Market in Spain (2021-2030)
• Table 16: Anti Snoring Devices Market in the Rest of Europe (2021-2030)
• Table 17: Anti Snoring Devices Market in Asia-Pacific (2021-2030)
• Table 18: Anti Snoring Devices Market in China (2021-2030)
• Table 19: Anti Snoring Devices Market in Japan (2021-2030)
• Table 20: Anti Snoring Devices Market in India (2021-2030)
• Table 21: Anti Snoring Devices Market in Australia (2021-2030)
• Table 22: Anti Snoring Devices Market in South Korea (2021-2030)
• Table 23: Anti Snoring Devices Market in Rest of Asia-Pacific (2021-2030)
• Table 24: Anti Snoring Devices Market in the Rest of the World (2021-2030)
• Table 25: Anti Snoring Devices Market in the Middle East (2021-2030)
• Table 26: Anti Snoring Devices Market in Africa (2021-2030)
• Table 27: Anti Snoring Devices Market in South America (2021-2030)

List of Figures

• Figure 1: Competitive Analysis
• Figure 2: Anti Snoring Devices Market in Global (2021-2030)
• Figure 3: Anti Snoring Devices Market in Global by Device Type (2021-2030)
• Figure 4: Anti Snoring Devices Market in Distribution Channel (2021-2030)
• Figure 5: Anti Snoring Devices Market in Global by Geography (2021-2030)
• Figure 6: Anti Snoring Devices Market in North America (2021-2030)
• Figure 7: Anti Snoring Devices Market in the United States (2021-2030)
• Figure 8: Anti Snoring Devices Market in Canada (2021-2030)
• Figure 9: Anti Snoring Devices Market in Mexico (2021-2030)
• Figure 10: Anti Snoring Devices Market in Europe (2021-2030)
• Figure 11: Anti Snoring Devices Market in France (2021-2030)
• Figure 12: Anti Snoring Devices Market in Germany (2021-2030)
• Figure 13: Anti Snoring Devices Market in United Kingdom (2021-2030)
• Figure 14: Anti Snoring Devices Market in Italy (2021-2030)
• Figure 15: Anti Snoring Devices Market in Spain (2021-2030)
• Figure 16: Anti Snoring Devices Market in the Rest of Europe (2021-2030)
• Figure 17: Anti Snoring Devices Market in Asia-Pacific (2021-2030)
• Figure 18: Anti Snoring Devices Market in China (2021-2030)
• Figure 19: Anti Snoring Devices Market in Japan (2021-2030)
• Figure 20: Anti Snoring Devices Market in India (2021-2030)
• Figure 21: Anti Snoring Devices Market in Australia (2021-2030)
• Figure 22: Anti Snoring Devices Market in South Korea (2021-2030)
• Figure 23: Anti Snoring Devices Market in Rest of Asia-Pacific (2021-2030)
• Figure 24: Anti Snoring Devices Market in the Rest of the World (2021-2030)
• Figure 25: Anti Snoring Devices Market in the Middle East (2021-2030)
• Figure 26: Anti Snoring Devices Market in Africa (2021-2030)
• Figure 27: Anti Snoring Devices Market in South America (2021-2030)
• Figure 28: Market Drivers
• Figure 29: Market Barriers
• Figure 30: Market Opportunities
• Figure 31: PORTER'S Five Force Analysis

Anti Snoring Devices Market by Device Type (Mandibular Advancement Devices, Tongue Stabilizing Devices, Continuous Positive Airway Pressure (CPAP) Devices, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the increasing prevalence of sleep apnea and its risk factors such as depression, COPD, obesity, surging number of sleep awareness campaigns and programs, among others across the globe.

The anti snoring devices market was valued at USD 1.61 billion in 2023, growing at a CAGR of 7.02% during the forecast period from 2024 to 2030 to reach USD 2.58 billion by 2030. The anti snoring devices market is poised for substantial growth, owing to the increasing prevalence of sleep disorders and risk factors such as depression, COPD, and obesity, among others, surge in the number of sleep awareness campaigns and programs highlighting the importance of sleep, the rising launch of technologically advanced sleep devices during the forecast period from 2024 to 2030.

Anti Snoring Devices Market Dynamics:

As per DelveInsight analysis, in 2021, the estimated total diagnosed cases of obstructive sleep apnea (OSA) in the 7MM region was 24,165,544. According to World Health Organization 2021, worldwide around 280 million people were suffering from depression in 2019. Several research studies have concluded that individuals going through depression may find it difficult to fall and stay asleep during the night or experience periods of excessive daytime sleepiness.

As per data from the Global Burden of Disease Study, there were 212.3 million prevalent cases of COPD reported in 2019 globally. COPD causes persistent and progressive respiratory symptoms, including difficulty in breathing, cough, and phlegm production. Thus, people with COPD will also have sleep apnea, the combination leading to a condition called "overlap syndrome".

Severe conditions such as obesity also aggravate the symptoms of various sleep disorders that may disrupt the sleep quality of an individual. In obese people, fat deposits in the upper respiratory tract narrow the airway; decreasing muscle activity in this region, leading to hypoxic and apneic episodes, ultimately resulting in sleep discrepancies such as sleep apnea. Thus, the interplay of all the above-mentioned factors is expected to boost the market for anti snoring devices during the forecasted period.

However, the various complications associated with anti snoring devices, the unreliable efficacy, and the lack of proven studies for the use of anti snoring devices, among others may act as restraining factors for the overall growth of the anti snoring devices during the forecast period.

Anti Snoring Devices Market Segment Analysis:

Anti Snoring Devices Market by Device Type (Mandibular Advancement Devices, Tongue Stabilizing Devices, Continuous Positive Airway Pressure (CPAP) Devices, and Others), Distribution Channel (Hospital and Retail Pharmacies, Online Pharmacies, and Others), Usability (Reusable and Disposable), Application (Vaccine, Insulin, Dermatology, and Others), End-User (Hospitals, Clinics, Homecare Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the device type segment of the anti-snoring devices market, the Continuous Positive Airway Pressure (CPAP) Devices category is projected to hold a considerable market share in 2023. The various advantages associated with CPAP therapy and the various product development activities such as launches are expected to drive the market demand for this category during the forecast period.

CPAP ventilators deliver a constant pressure of air, both while inhaling and exhaling, due to which CPAP ventilators form one of the most common forms of treatment procedures for the management of mild obstructive sleep apnea. CPAP includes automatic PAP therapy (APAP) as well, which uses an automatically adjusting positive airway pressure machine to treat obstructive sleep apnea. APAP devices may also be referred to as auto-titrating CPAP or auto-CPAP machines.

Moreover, in February 2024, ResMed announced the launch of its AirFit F40 ultra-compact, full-face mask indicated for sleep apnea. The device offers the comfort of smaller masks without sacrificing performance, thus helping with sleep apnea therapy compliance for users of high-pressure continuous positive airway pressure (CPAP) treatment.

Thus, all the above-mentioned factors are expected to boost the market for the CPAP category, thereby escalating the overall market for anti snoring devices during the forecast period.

North America is expected to dominate the overall anti snoring devices market:

North America is expected to account for the highest proportion of the Anti Snoring Devices market in 2023, out of all regions North America is expected to dominate the overall Anti Snoring Devices market during the forecast period.

The major factors driving the market for anti snoring devices in North America are the rising prevalence of sleep-related issues among the population, the presence of key organizations for creating awareness, and product development activities, among other activities across the region during the forecast period. As per data by the Centers for Disease Control and Prevention 2022, around 17.8% of adults had trouble staying asleep owing to various reasons such as sleep apnea in the US in 2020.

Further, the American Sleep Apnea Association 2023 stated that nearly 84 million people which means one in three American adults do not get the required uninterrupted sleep due to snoring and breathing difficulties regularly.

The presence of organizations such as the National Sleep Foundation (NSF), independently creates Sleep Awareness Week each year as the flagship campaign for sleep health awareness and education in the US.

NSF recognizes evidence and consensus-based best practices for sleep health throughout Sleep Awareness Week, including professional advice and useful pointers to assist people in getting the necessary quantity and quality of sleep.

Thus, the interplay of all the aforementioned factors is likely to fuel the regional market growth and demand for anti snoring devices in North America during the forecasted period from 2024 to 2030.

Anti Snoring Devices Market Key Players:

Some of the key market players operating in the Anti Snoring Devices market include Koninklijke Philips NV, Apnea Sciences, ResMed, SomnoMed, GSK plc., Meditas, Evantis Inc., Rotech Healthcare, The Pure Sleep Company, Innovative Health Technologies, Tomed GmbH, Fisher and Paykel Healthcare Limited, Whole You Inc., AccuMED Corporation, Vyaire Medical, and others.

Recent Developmental Activities in the Anti Snoring Devices Market:

• In July 2024, Snorles, a leading innovator in sleep technology, announced the launch of its latest product, GenioFlex, which offers a fresh approach to managing snoring without the need for intrusive nighttime devices. Snorles GenioFlex distinguishes itself by its unique daytime functionality, eliminating the need for users to wear or use it during sleep hours. Unlike traditional anti-snoring products that may disrupt sleep quality, GenioFlex seamlessly integrates into daily routines, providing effective snoring management without compromising nighttime rest.
• In May 2022, Illusion Aligners, known for bringing revolutionary technologies to the dental industry, launched its new Anti-Snoring Device (ASD). The oral anti-snoring device by Illusion Aligners is easy to wear, effective, and is also comfortable. It can help experience undisturbed and restful sleep every night.
• In February 2021, the U.S. Food and Drug Administration authorized the marketing of a new prescription-only device, the eXciteOSA mouthpiece, intended to reduce snoring and mild obstructive sleep apnea. Unlike devices used while patients sleep, this was the first device used while awake, intended to improve tongue muscle function, which in time can help prevent the tongue from collapsing backward and obstructing the airway during sleep.

Key Takeaways from the Anti Snoring Devices Market Report Study:

• Market size analysis for current Anti Snoring Devices size (2023), and market forecast for 6 years (2024 to 2030)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the Anti Snoring Devices market.
• Various opportunities available for the other competitors in the Anti Snoring Devices market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030?
• Which are the top-performing regions and countries in the current Anti Snoring Devices market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for anti snoring devices market growth in the coming future?

Target audience who can be benefited from this Anti Snoring Devices Market Report Study:

• Anti Snoring Devices product providers
• Research organizations and consulting companies
• Anti Snoring Devices - related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in Anti Snoring Devices
• Various end-users who want to know more about the Anti Snoring Devices market and the latest technological developments in the Anti Snoring Devices market.

Frequently Asked Questions for the Anti Snoring Devices Market:

1. What are Anti Snoring Devices?

Anti snoring devices are devices that help keep the nasal passages open and relieve snoring. Nasal snoring can be relieved with the use of nasal anti-snoring devices such as nasal strips, and nasal dilators, among others that keep the nostrils open during sleep.

2. What is the market for Anti Snoring Devices?

The anti snoring devices market was valued at USD 1.61 billion in 2023, growing at a CAGR of 7.02% during the forecast period from 2024 to 2030 to reach USD 2.58 billion by 2030.

3. What are the drivers for the Anti Snoring Devices market?

The anti snoring devices market is poised for substantial growth, owing to the increasing prevalence of sleep disorders and risk factors such as depression, COPD, and obesity, among others, the surge in the number of sleep awareness campaigns and programs highlighting the importance of sleep, the rising launch of technologically advanced sleep devices during the forecast period from 2024 to 2030.

4. Who are the key players operating in the Anti Snoring Devices market?

Some of the key market players operating in the Anti Snoring Devices market include Koninklijke Philips NV, Apnea Sciences, ResMed, SomnoMed, GSK plc., Meditas, Evantis Inc., Rotech Healthcare, The Pure Sleep Company, Innovative Health Technologies, Tomed GmbH, Fisher and Paykel Healthcare Limited, Whole You Inc., AccuMED Corporation, Vyaire Medical, and others.

5. Which region has the highest share in the Anti Snoring Devices market?

North America is expected to account for the highest proportion in the Anti Snoring Devices market in 2023, out of all regions. The major factors driving the market for anti snoring devices in North America are the rising prevalence of sleep-related issues among the population, the presence of key organizations for creating awareness, and product development activities, among other activities across the region during the forecast period.

Table of Contents

1. Anti Snoring Devices Market Report Introduction

• 1.1. Scope of the Study
• 1.2. Market Segmentation
• 1.3. Market Assumption

2. Anti Snoring Devices Market Executive Summary

• 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

• 4.1. The United States
• 4.2. Europe
• 4.3. Japan
• 4.4. China

5. Anti Snoring Devices Market Key Factors Analysis

• 5.1. Anti Snoring Devices Market Drivers
  • 5.1.1. Increasing prevalence of sleep disorders and their risk factors such as depression, COPD, obesity, among others
  • 5.1.2. Surge in the number of sleep awareness campaigns and programs highlighting the importance of sleep
  • 5.1.3. Rising launch of technologically advanced sleep devices
• 5.2. Anti Snoring Devices Market Restraints and Challenges
  • 5.2.1. Complications associated with the devices
  • 5.2.2. Unreliable efficacy and lack of proven studies for the use of anti snoring devices
• 5.3. Anti Snoring Devices Market Opportunities
  • 5.3.1. Increasing research and development activities in sleep devices
  • 5.3.2. Increasing adoption of artificial intelligence technology in sleep tracking and assistance

6. Anti Snoring Devices Market Porter's Five Forces Analysis

• 6.1. Bargaining Power of Suppliers
• 6.2. Bargaining Power of Consumers
• 6.3. Threat of New Entrants
• 6.4. Threat of Substitutes
• 6.5. Competitive Rivalry

7. Anti Snoring Devices Market Assessment

• 7.1. By Device Type
  • 7.1.1. Mandibular Advancement Devices
  • 7.1.2. Tongue Stabilizing Devices
  • 7.1.3. Continuous Positive Airway Pressure (CPAP) Devices
  • 7.1.4. Others
• 7.2. By Distribution Channel
  • 7.2.1. Hospital and Retail Pharmacies
  • 7.2.2. Online Pharmacies
  • 7.2.3. Others
• 7.3. By Geography
  • 7.3.1. North America
    • 7.3.1.1. United States Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.1.2. Canada Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.1.3. Mexico Anti Snoring Devices Market Size in USD Million (2021-2030)
  • 7.3.2. Europe
    • 7.3.2.1. France Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.2.2. Germany Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.2.3. United Kingdom Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.2.4. Italy Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.2.5. Spain Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.2.6. Rest of Europe Anti Snoring Devices Market Size in USD Million (2021-2030)
  • 7.3.3. Asia-Pacific
    • 7.3.3.1. China Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.3.2. Japan Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.3.3. India Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.3.4. Australia Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.3.5. South Korea Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.3.6. Rest of Asia-Pacific Anti Snoring Devices Market Size in USD Million (2021-2030)
  • 7.3.4. Rest of the World (RoW)
    • 7.3.4.1. Middle East Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.4.2. Africa Anti Snoring Devices Market Size in USD Million (2021-2030)
    • 7.3.4.3. South America Anti Snoring Devices Market Size in USD Million (2021-2030)

8. Anti Snoring Devices Market Company and Product Profiles

• 8.1. Koninklijke Philips NV
  • 8.1.1. Company Overview
  • 8.1.2. Company Snapshot
  • 8.1.3. Financial Overview
  • 8.1.4. Product Listing
  • 8.1.5. Entropy
• 8.2. Apnea Sciences
  • 8.2.1. Company Overview
  • 8.2.2. Company Snapshot
  • 8.2.3. Financial Overview
  • 8.2.4. Product Listing
  • 8.2.5. Entropy
• 8.3. ResMed
  • 8.3.1. Company Overview
  • 8.3.2. Company Snapshot
  • 8.3.3. Financial Overview
  • 8.3.4. Product Listing
  • 8.3.5. Entropy
• 8.4. SomnoMed
  • 8.4.1. Company Overview
  • 8.4.2. Company Snapshot
  • 8.4.3. Financial Overview
  • 8.4.4. Product Listing
  • 8.4.5. Entropy
• 8.5. GSK plc.
  • 8.5.1. Company Overview
  • 8.5.2. Company Snapshot
  • 8.5.3. Financial Overview
  • 8.5.4. Product Listing
  • 8.5.5. Entropy
• 8.6. Meditas
  • 8.6.1. Company Overview
  • 8.6.2. Company Snapshot
  • 8.6.3. Financial Overview
  • 8.6.4. Product Listing
  • 8.6.5. Entropy
• 8.7. Evantis Inc.
  • 8.7.1. Company Overview
  • 8.7.2. Company Snapshot
  • 8.7.3. Financial Overview
  • 8.7.4. Product Listing
  • 8.7.5. Entropy
• 8.8. Rotech Healthcare
  • 8.8.1. Company Overview
  • 8.8.2. Company Snapshot
  • 8.8.3. Financial Overview
  • 8.8.4. Product Listing
  • 8.8.5. Entropy
• 8.9. The Pure Sleep Company
  • 8.9.1. Company Overview
  • 8.9.2. Company Snapshot
  • 8.9.3. Financial Overview
  • 8.9.4. Product Listing
  • 8.9.5. Entropy
• 8.10. Innovative Health Technologies
  • 8.10.1. Company Overview
  • 8.10.2. Company Snapshot
  • 8.10.3. Financial Overview
  • 8.10.4. Product Listing
  • 8.10.5. Entropy
• 8.11. Tomed GmbH
  • 8.11.1. Company Overview
  • 8.11.2. Company Snapshot
  • 8.11.3. Financial Overview
  • 8.11.4. Product Listing
  • 8.11.5. Entropy
• 8.12. Fisher and Paykel Healthcare Limited
  • 8.12.1. Company Overview
  • 8.12.2. Company Snapshot
  • 8.12.3. Financial Overview
  • 8.12.4. Product Listing
  • 8.12.5. Entropy
• 8.13. Whole You Inc.
  • 8.13.1. Company Overview
  • 8.13.2. Company Snapshot
  • 8.13.3. Financial Overview
  • 8.13.4. Product Listing
  • 8.13.5. Entropy
• 8.14. AccuMED Corporation
  • 8.14.1. Company Overview
  • 8.14.2. Company Snapshot
  • 8.14.3. Financial Overview
  • 8.14.4. Product Listing
  • 8.14.5. Entropy
• 8.15. Vyaire Medical
  • 8.15.1. Company Overview
  • 8.15.2. Company Snapshot
  • 8.15.3. Financial Overview
  • 8.15.4. Product Listing
  • 8.15.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us